Delivery Order SPE2DB24D3013-SPE2DB24FFGBG

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product KERENDIA 10 MG TABLET 30S. The $4,979.04 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a major defense agency, and has an ultimate completion date of August 1, 2024. The contract is not set aside for a specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,360,809 units of the pharmaceutical product KERENDIA 10 MG TABLET 30S. The $2,205.60 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,997.56 Firm Fixed Price delivery order contract is for the provision of the pharmaceutical product KERENDIA 20 MG TABLET 30S. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 90S to the Defense Logistics Agency (DLA). The $4,859.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication KERENDIA 10 MG TABLET 30S to the Defense Logistics Agency (DLA). The award, valued at $2,205.52, is a firm fixed-price delivery order with a final completion date of July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "KERENDIA 20 MG TABLET 90S". The $2,878.08 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $6,029.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and covers the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $1,146.75, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the medication KERENDIA 10 MG TABLET 30S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,208.98 award is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 90S to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,988.39 firm fixed-price delivery order contract is for the delivery of KERENDIA 10 MG TABLET 30S, a medical product, to support federal government medical programs. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGBG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of $2,218.36 worth of the pharmaceutical product KERENDIA 10 MG TABLET 30S. This award is part of a larger $999,999,999.00 IDC that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill these types of government contracts for essential medical commodities.

Generated 10/2/24, 10:22 AM